Comparison of the Effect of Different Treatment Doses of Intrastromal Vancomycin in a Rabbit Model of Methicillin-Resistant Staphylococcus Aureus (MRSA) Keratitis
dc.authorid | /0000-0001-5454-3113 | |
dc.contributor.author | Bayrak, Abdullah | |
dc.contributor.author | Celebi, Serdal | |
dc.contributor.author | Avcioglu, Fatma | |
dc.contributor.author | Alkan, Yunus | |
dc.date.accessioned | 2024-09-25T19:57:30Z | |
dc.date.available | 2024-09-25T19:57:30Z | |
dc.date.issued | 2024 | |
dc.department | Abant İzzet Baysal Üniversitesi | en_US |
dc.description.abstract | PurposeTo compare the effect of different doses of vancomycin on a rabbit model of MRSA keratitis.MethodsTwenty-four eyes of 24 New-Zealand White rabbits were included in the study. MRSA keratitis was applied to 24 left eyes of 24 New Zealand rabbits. Twenty-four hours after MRSA inoculation; 0.5 mg/0.1 mL, 1 mg/0.1 mL, and 2 mg/0.1 mL and balanced salt solution were administered to 6 rabbits in 4 groups, respectively.ResultsThe effect of different doses of vancomycin on reducing bacterial load was found to be statistically significant when each was compared to the control group (p = 0.006). When comparing the dosages with each other, no superiority was shown (p = 0.297, p = 0.749, p = 0.262 respectively). There was a significant increase in the posttreatment total clinical score in the control and 2 mg/0.1 mL groups compared to the pretreatment score (p = 0.001, p = 0.001 respectively).ConclusionIt is emphasized that necessary treatment can be achieved by administering less antibiotic (0.5 mg/0.1 mL) to the corneal intrastromal area. | en_US |
dc.identifier.doi | 10.1080/09273948.2024.2382928 | |
dc.identifier.issn | 0927-3948 | |
dc.identifier.issn | 1744-5078 | |
dc.identifier.pmid | 39115284 | en_US |
dc.identifier.scopus | 2-s2.0-85200897459 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1080/09273948.2024.2382928 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/13458 | |
dc.identifier.wos | WOS:001286797200001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Inc | en_US |
dc.relation.ispartof | Ocular Immunology And Inflammation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | YK_20240925 | en_US |
dc.subject | Corneal intrastromal therapy | en_US |
dc.subject | fortified topical drop | en_US |
dc.subject | keratitis | en_US |
dc.subject | Methicillin-resistant Staphylococcus aureus(MRSA) | en_US |
dc.subject | vancomycin | en_US |
dc.title | Comparison of the Effect of Different Treatment Doses of Intrastromal Vancomycin in a Rabbit Model of Methicillin-Resistant Staphylococcus Aureus (MRSA) Keratitis | en_US |
dc.type | Article | en_US |